Symbiose aus Chemie und Medizin — zielgerichtet gegen KrebsMolekulare Medizin

被引:0
作者
Svenja Mayer-Wrangowski
Daniel Rauh
机构
[1] Chemische Biologie,Fakultät für Chemie
[2] FB Chemie — Chemische Biologie,Technische Universität Dortmund
关键词
D O I
10.1007/s12268-012-0195-7
中图分类号
学科分类号
摘要
引用
收藏
页码:376 / 379
页数:3
相关论文
共 36 条
[1]  
Rabiller M.(2010)Proteus in the world of proteins: conformational changes in protein kinases Arch Pharm 343 193-206
[2]  
Getlik M.(1976)DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA Nature 260 170-173
[3]  
Klüter S.(2001)Oncogenic kinase signalling Nature 411 355-65
[4]  
Stehelin D.(2009)Targeting cancer with small molecule kinase inhibitors Nat Rev Cancer 9 28-39
[5]  
Varmus H.E.(2009)Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer Proc Natl Acad Sci USA 106 18351-6
[6]  
Bishop J.M.(2006)Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 2408-2417
[7]  
Blume-Jensen P.(2009)Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology J Clin Oncol 27 5650-5659
[8]  
Hunter T.(2010)Frequent and Focal Sci Transl Med 2 62ra93-1703
[9]  
Zhang J.(2010) Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer N Engl J Med 363 1693-210
[10]  
Yang P.L.(2011)Anaplastic lymphoma kinase inhibition in non-smallcell lung cancer Bioorg Chem 39 192-3926